Wnt/Frizzled signaling in hepatocellular carcinoma.

The Wnt/Frizzled (FZD) signaling cascade is important for cell fate determination during embryonic development as well as maintaining tissue homeostasis in the adult. In addition to these physiologic roles, studies have shown that deregulation of Wnt/FZD signaling occurs during carcinogenesis. As an example, over 90% of the colorectal cancers have mutations in adenomatous polyposis coli (APC) or beta-catenin genes. In addition, hepatocellular carcinoma (HCC) is another tumor with frequent aberrant activation of beta-catenin signaling. Nuclear and/or cellular beta-catenin accumulation, a hallmark of the activated canonical Wnt/FZD signaling, has been observed in 33-67% of tumors. However, mutations of APC and/or beta-catenin genes are found only in about 20-30% of HCCs, suggesting that the predominant mechanism(s) activating Wnt/FZD signaling pathway may be different from that found in colorectal cancers. There is accumulating evidence to suggest that regulatory mechanisms other than mutations involving beta-catenin or proteins in its destruction complex, many of which involve upstream components of the Wnt/FZD cascade, are important in HCC. Furthermore, information on the target genes of Wnt/FZD signaling and their roles in hepatocarcinogenesis is limited despite the recent discovery of several candidate genes. This review focuses on the alterations of Wnt/FZD signaling pathways and their relationship to the pathogenesis of HCC. A better understanding of the precise mechanisms of altered Wnt/FZD signaling may provide new molecular targets for therapy of HCC.

[1]  V. Chopra,et al.  Effect of the Wingless (wg1) mutation on wing and haltere development in Drosophila melanogaster. , 1976, Developmental biology.

[2]  P. Cohen,et al.  Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. , 1980, European journal of biochemistry.

[3]  Harold E. Varmus,et al.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome , 1982, Cell.

[4]  P. Cohen,et al.  Glycogen synthase kinase-3 from rabbit skeletal muscle. , 2005, Methods in enzymology.

[5]  S Ichii,et al.  Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. , 1992, Human molecular genetics.

[6]  R. Moon,et al.  Identification of distinct classes and functional domains of Wnts through expression of wild-type and chimeric proteins in Xenopus embryos , 1995, Molecular and cellular biology.

[7]  A. Harris,et al.  Wnt5a cloning, expression, and up-regulation in human primary breast cancers. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  R. Iozzo,et al.  Aberrant expression of the growth factor Wnt-5A in human malignancy. , 1995, Cancer research.

[9]  H Clevers,et al.  Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties , 1996, Molecular and cellular biology.

[10]  Jeremy Nathans,et al.  A new member of the frizzled family from Drosophila functions as a Wingless receptor , 1996, Nature.

[11]  P. Polakis,et al.  Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. , 1996, Science.

[12]  Paul Polakis,et al.  Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.

[13]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[14]  Mariann Bienz,et al.  LEF-1, a Nuclear Factor Coordinating Signaling Inputs from wingless and decapentaplegic , 1997, Cell.

[15]  M. Mahadevappa,et al.  SARPs: a family of secreted apoptosis-related proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Moon,et al.  Modulation of embryonic intracellular Ca2+ signaling by Wnt-5A. , 1997, Developmental biology.

[17]  Hans Clevers,et al.  Armadillo Coactivates Transcription Driven by the Product of the Drosophila Segment Polarity Gene dTCF , 1997, Cell.

[18]  Bert Vogelstein,et al.  Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer , 1998 .

[19]  Y. Nakamura,et al.  Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. , 1998, Cancer research.

[20]  Y. Nakamura,et al.  Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. , 1998, Cancer research.

[21]  A. Sparks,et al.  Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. , 1998, Cancer research.

[22]  Hans Clevers,et al.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 , 1998, Nature Genetics.

[23]  L. Williams,et al.  Bridging of β-catenin and glycogen synthase kinase-3β by Axin and inhibition of β-catenin-mediated transcription , 1998 .

[24]  M. Buendia,et al.  Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Botstein,et al.  WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Williams,et al.  Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Polakis,et al.  Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. , 1998, Current biology : CB.

[28]  K. Sugimachi,et al.  A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. , 1998, The EMBO journal.

[30]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[31]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[32]  Y. Morishita,et al.  Amplification of c-myc in Hepatocellular Carcinoma: Correlation with Clinicopathologic Features, Proliferative Activity and p53 Overexpression , 1999, Oncology.

[33]  R. Moon,et al.  XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. , 1999, Development.

[34]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.

[35]  S. Lomvardas,et al.  A GSK3β Phosphorylation Site in Axin Modulates Interaction with β-Catenin and Tcf-Mediated Gene Expression , 1999 .

[36]  R. Moon,et al.  Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in aG-protein-dependent manner , 1999, Current Biology.

[37]  S. Lomvardas,et al.  A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression. , 1999, Biochemical and biophysical research communications.

[38]  G. Thomas,et al.  Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. , 1999, Cancer research.

[39]  Paul Polakis,et al.  The oncogenic activation of β-catenin , 1999 .

[40]  M. Matsuda,et al.  β-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection , 1999 .

[41]  S. Albrecht,et al.  Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. , 1999, Cancer research.

[42]  M. Matsuda,et al.  Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. , 1999, The American journal of pathology.

[43]  Hideki Yamamoto,et al.  Phosphorylation of Axin, a Wnt Signal Negative Regulator, by Glycogen Synthase Kinase-3β Regulates Its Stability* , 1999, The Journal of Biological Chemistry.

[44]  J. Nathans,et al.  A new secreted protein that binds to Wnt proteins and inhibits their activites , 1999, Nature.

[45]  P. Polakis.  The oncogenic activation of beta-catenin. , 1999, Current opinion in genetics & development.

[46]  Jan Bayer,et al.  Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity , 1999, Oncogene.

[47]  Yusuke Nakamura,et al.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.

[48]  A. Üren,et al.  Secreted Frizzled-related Protein-1 Binds Directly to Wingless and Is a Biphasic Modulator of Wnt Signaling* , 2000, The Journal of Biological Chemistry.

[49]  R. Moon,et al.  Ca2+/Calmodulin-dependent Protein Kinase II Is Stimulated by Wnt and Frizzled Homologs and Promotes Ventral Cell Fates in Xenopus* , 2000, The Journal of Biological Chemistry.

[50]  Y. Jeng,et al.  Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. , 2000, The American journal of pathology.

[51]  T. Dale,et al.  Sequence variants of the axin gene in breast, colon, and other cancers: An analysis of mutations that interfere with GSK3 binding , 2000, Genes, chromosomes & cancer.

[52]  Yoichi Kato,et al.  LDL-receptor-related proteins in Wnt signal transduction , 2000, Nature.

[53]  Andrew Tomlinson,et al.  arrow encodes an LDL-receptor-related protein essential for Wingless signalling , 2000, Nature.

[54]  William C. Skarnes,et al.  An LDL-receptor-related protein mediates Wnt signalling in mice , 2000, Nature.

[55]  M. Buendia,et al.  Activation of β-catenin in epithelial and mesenchymal hepatoblastomas , 2000, Oncogene.

[56]  F. McCormick,et al.  Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C. , 2000, Journal of Biological Chemistry.

[57]  F. McCormick,et al.  Wnt Signaling to β-Catenin Involves Two Interactive Components , 2000, The Journal of Biological Chemistry.

[58]  R. Nusse,et al.  Pathway specificity by the bifunctional receptor frizzled is determined by affinity for wingless. , 2000, Molecular cell.

[59]  A. Penzo-Méndez,et al.  The C‐terminal cytoplasmic Lys‐Thr‐X‐X‐X‐Trp motif in frizzled receptors mediates Wnt/β‐catenin signalling , 2000, The EMBO journal.

[60]  M. Buendia,et al.  Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. , 2000, Oncogene.

[61]  K. Endo,et al.  Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. , 2000, Human pathology.

[62]  H. Kirikoshi,et al.  Expression profiles of 10 members of Frizzled gene family in human gastric cancer. , 2001, International journal of oncology.

[63]  P. Cohen,et al.  GSK3 takes centre stage more than 20 years after its discovery. , 2001, The Biochemical journal.

[64]  F. Bertrand,et al.  Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation , 2001, Oncogene.

[65]  M. Yuen,et al.  Expression of c‐Myc, c‐Fos, and c‐Jun in hepatocellular carcinoma , 2001, Cancer.

[66]  Karine Hovanes,et al.  β-catenin–sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer , 2001, Nature Genetics.

[67]  A. Cadoret,et al.  Hepatomegaly in Transgenic Mice Expressing an Oncogenic Form of β-Catenin , 2001 .

[68]  A. Cadoret,et al.  Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. , 2001, Cancer research.

[69]  Jack A. Taylor,et al.  CTNNB1 mutations and β‐catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1 † , 2001, Molecular carcinogenesis.

[70]  Molecular cloning and characterization of human WNT11. , 2001, International journal of molecular medicine.

[71]  G. Thomas,et al.  Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. , 2001, Gastroenterology.

[72]  H. Kirikoshi,et al.  Up-regulation of Frizzled-7 (FZD7) in human gastric cancer. , 2001, International journal of oncology.

[73]  F. Bertrand,et al.  Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. , 2001, Oncogene.

[74]  Yan Li,et al.  LDL-receptor-related protein 6 is a receptor for Dickkopf proteins , 2001, Nature.

[75]  A. Harwood,et al.  Regulation of GSK-3 A Cellular Multiprocessor , 2001, Cell.

[76]  X. Guan,et al.  Prognostic significance of c‐myc and AIB1 amplification in hepatocellular carcinoma , 2002, Cancer.

[77]  Mei Wang,et al.  Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues. , 2002, World journal of gastroenterology.

[78]  J. Rubin,et al.  Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas , 2002, Oncogene.

[79]  Jan Kitajewski,et al.  New targets of β-catenin signaling in the liver are involved in the glutamine metabolism , 2002, Oncogene.

[80]  S. Wong,et al.  Expression of frizzled‐related protein and Wnt‐signalling molecules in invasive human breast tumours , 2002, The Journal of pathology.

[81]  T. Terada,et al.  Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma. , 2002, Oncology reports.

[82]  M. Bittner,et al.  Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. , 2002, Cancer cell.

[83]  J. Shimazaki,et al.  Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[84]  Xin-da Zhou,et al.  Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma. , 2002, World journal of gastroenterology.

[85]  Hans Clevers,et al.  Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors , 2002, Molecular and Cellular Biology.

[86]  R. Holcombe,et al.  Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma , 2002, Molecular pathology : MP.

[87]  Christof Niehrs,et al.  Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. , 2002, Nature.

[88]  David I. Smith,et al.  Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas , 2002, Oncogene.

[89]  C. Hartmann,et al.  Cbfa 1-independent decrease in osteoblast proliferation , osteopenia , and persistent embryonic eye vascularization in mice deficient in Lrp 5 , a Wnt coreceptor , 2002 .

[90]  C. Desbois-Mouthon,et al.  Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells. , 2002, Hepatology.

[91]  Christof Niehrs,et al.  Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling , 2002, Nature.

[92]  C. Jomary,et al.  Secreted Frizzled-related proteins: searching for relationships and patterns. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[93]  Elaine Fuchs,et al.  Intercellular adhesion, signalling and the cytoskeleton , 2002, Nature Cell Biology.

[94]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[95]  Jeffrey D. Axelrod,et al.  A Second Canon , 2003 .

[96]  M. Romeih,et al.  Wnt signaling in hepatocellular carcinoma: Analysis of mutation and expression of beta‐catenin, T‐cell factor‐4 and glycogen synthase kinase 3‐beta genes , 2003, Journal of gastroenterology and hepatology.

[97]  J. Behrens,et al.  The Wnt signaling pathway and its role in tumor development , 2003, Journal of Cancer Research and Clinical Oncology.

[98]  A. Bradley,et al.  Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. , 2003, Cancer cell.

[99]  T. Devereux,et al.  Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. , 2003, Toxicology and applied pharmacology.

[100]  Christian Pilarsky,et al.  WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer , 2003, The Journal of pathology.

[101]  H. Seow,et al.  GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma. , 2003, Cancer letters.

[102]  P. Schirmacher,et al.  Beta‐catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E‐cadherin and accumulation of p53, but not with expression of conventional WNT‐1 target genes , 2003, The Journal of pathology.

[103]  Randall T Moon,et al.  A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. , 2003, Developmental cell.

[104]  R. Krishnan,et al.  GSK-3 phosphorylation and alteration of -catenin in hepatocellular carcinoma , 2003 .

[105]  David Strutt,et al.  Frizzled signalling and cell polarisation in Drosophila and vertebrates , 2003, Development.

[106]  P. Schirmacher,et al.  Overexpression of Human Dickkopf-1, an Antagonist of wingless/WNT Signaling, in Human Hepatoblastomas and Wilms’ Tumors , 2003, Laboratory Investigation.

[107]  Biao He,et al.  Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression , 2003, Oncogene.

[108]  Yoshiaki Kawano,et al.  Secreted antagonists of the Wnt signalling pathway , 2003, Journal of Cell Science.

[109]  S. Hirohashi,et al.  Overexpression of orphan G‐protein–coupled receptor, Gpr49, in human hepatocellular carcinomas with β‐catenin mutations , 2003, Hepatology.

[110]  M. Matsuda,et al.  Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis , 2003, International journal of cancer.

[111]  M. Obata,et al.  Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis. , 2003, Carcinogenesis.

[112]  K. Uematsu,et al.  Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. , 2003, Cancer research.

[113]  M. Emi,et al.  Up-regulation and overproduction of DVL-1, the human counterpart of the Drosophila dishevelled gene, in cervical squamous cell carcinoma. , 2003, Oncology reports.

[114]  P. Liang,et al.  Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection. , 2004, World journal of gastroenterology.

[115]  E. Andreu,et al.  Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia , 2004, British Journal of Cancer.

[116]  S. Fuchs,et al.  The many faces of β-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer , 2004, Oncogene.

[117]  M. Labbozzetta,et al.  Expression of WISPs and of Their Novel Alternative Variants in Human Hepatocellular Carcinoma Cells , 2004, Annals of the New York Academy of Sciences.

[118]  Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosis. , 2004, Laboratory investigation; a journal of technical methods and pathology.

[119]  M. Giovannini,et al.  Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[120]  Keith Brennan,et al.  Truncated mutants of the putative Wnt receptor LRP6/Arrow can stabilize β-catenin independently of Frizzled proteins , 2004, Oncogene.

[121]  B. Doble,et al.  Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? , 2004, Biochemical Society transactions.

[122]  I. Ng,et al.  High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma. , 2004, Human pathology.

[123]  Yonghe Li,et al.  LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering β-catenin subcellular distribution , 2004, Oncogene.

[124]  Kazuo Suzuki,et al.  Identification of the leukocyte cell‐derived chemotaxin 2 as a direct target gene of β‐catenin in the liver , 2004, Hepatology.

[125]  Biao He,et al.  Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer , 2004, Cancer Research.

[126]  T. Iwatsubo,et al.  Biochemical Characterization of the Drosophila Wingless Signaling Pathway Based on RNA Interference , 2004, Molecular and Cellular Biology.

[127]  Jie J. Zheng,et al.  Multiple Mechanisms for Wnt11-mediated Repression of the Canonical Wnt Signaling Pathway* , 2004, Journal of Biological Chemistry.

[128]  M. Bianchi,et al.  Functional Studies of Shaggy/Glycogen Synthase Kinase 3 Phosphorylation Sites in Drosophila melanogaster , 2004, Molecular and Cellular Biology.

[129]  T. Kurihara,et al.  Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. , 2004, International journal of oncology.

[130]  D. Nelson,et al.  Stabilized β-catenin promotes hepatocyte proliferation and inhibits TNFα-induced apoptosis , 2004, Laboratory Investigation.

[131]  C. Wen,et al.  Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402 , 2004, Cell Research.

[132]  Jian Yu,et al.  Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. , 2004, World journal of gastroenterology.

[133]  J. Hsieh.  Specificity of WNT-receptor interactions. , 2004, Frontiers in bioscience : a journal and virtual library.

[134]  A. Huvos,et al.  Expression of LDL receptor‐related protein 5 (LRP5) as a novel marker for disease progression in high‐grade osteosarcoma , 2004, International journal of cancer.

[135]  M. Walker,et al.  Analysis of Wnt Gene Expression in Prostate Cancer , 2004, Cancer Research.

[136]  Miran Kim,et al.  Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. , 2004, Gastroenterology.

[137]  Y. Dragan,et al.  Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin‐SV40 T antigen transgenic rats , 2004, Molecular carcinogenesis.

[138]  Miran Kim,et al.  Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. , 2005, Journal of hepatology.

[139]  W. Park,et al.  Mutations of β‐catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[140]  D. Ahlquist,et al.  Aberrant methylation of secreted frizzled‐related protein genes in esophageal adenocarcinoma and Barrett's esophagus , 2005, International journal of cancer.

[141]  S. Fan,et al.  HDPR1, a novel inhibitor of the WNT/β-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing , 2005, Oncogene.

[142]  A. Bell,et al.  Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. , 2005, Gastroenterology.

[143]  D. Berry,et al.  Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. , 2005, European journal of cancer.

[144]  R. Nitschke,et al.  Coordinated expression of cyclin D1 and LEF‐1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[145]  Hiroyuki Yamamoto,et al.  Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers , 2005, Oncogene.

[146]  A. Muñoz,et al.  The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer , 2005, Oncogene.

[147]  S. Thorgeirsson,et al.  Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. , 2005, Journal of hepatology.

[148]  Y. Fujii,et al.  Expression and prognostic roles of PABPC1 in esophageal cancer: correlation with tumor progression and postoperative survival. , 2006, Oncology reports.

[149]  I. Blanco,et al.  [Familial adenomatous polyposis]. , 2006, Gastroenterologia y hepatologia.

[150]  W. Foulkes,et al.  Familial Adenomatous Polyposis , 2006, The American Journal of Gastroenterology.